Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo-Reference-Cited by-同舟云学术

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo

Published:2017-06-29 Issue:53 Volume:8 Page:90996-91008
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Takeda Hiroyuki¹²,Okada Masashi¹,Kuramoto Kenta¹,Suzuki Shuhei¹²,Sakaki Hirotsugu³,Sanomachi Tomomi¹,Seino Shizuka¹⁴,Yoshioka Takashi²,Hirano Hirofumi⁵,Arita Kazunori⁵,Kitanaka Chifumi¹⁴

Affiliation:

1. Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan

2. Department of Clinical Oncology, Yamagata University School of Medicine, Yamagata, Japan

3. Department of Obstetrics and Gynecology, Yamagata University School of Medicine, Yamagata, Japan

4. Research Institute for Promotion of Medical Sciences, Yamagata University Faculty of Medicine, Yamagata, Japan

5. Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meningioma animal models: a systematic review and meta-analysis;Journal of Translational Medicine;2023-10-28

2. Preclinical Models of Meningioma;Advances in Experimental Medicine and Biology;2023

3. Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas;Clinical Cancer Research;2022-10-25

4. Emerging systemic treatment options in meningioma;Journal of Neuro-Oncology;2022-10-01

5. Gemcitabine Cooperates with Everolimus to Inhibit the Growth of and Sensitize Malignant Meningioma Cells to Apoptosis Induced by Navitoclax, an Inhibitor of Anti-Apoptotic BCL-2 Family Proteins;Cancers;2022-03-27